Media Mentions

Filter By Core Concepts
183 Results
Article
Rare Disease on Payer’s Minds
PharmaLive
6/15/2022
Article
Lack of Diversity in Clinical Trials Isn’t Just a Recruiting Problem—It’s a Data Problem
MedCity News
5/24/2022
Article
Pivotal Trials For EU Approval Still Underrepresent Minorities, Study Finds
Informa
5/6/2022
Article
Race is Often Overlooked in Key Clinical Trial Data Used to Win New Drug Approvals in Europe
STAT News
5/4/2022
Report
Central Nervous System Therapeutics Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
Yahoo! Finance
4/22/2022
Article
Over 10,000 Diseases And Only 50 Drugs Approved In 2021. To Improve Pharma R&D Efficiency We Need To Understand It.
Forbes
4/11/2022
Article
Why Clinical Trials Need Expert Support for Ongoing Success
Clinical Trials Arena
4/6/2022
Article
Restoring Trust in Clinical Trials Among Black Communities
MedCity News
3/18/2022
Article
Measuring Patient Satisfaction as a Primary Outcome for Patient-Centric Initiatives
Applied Clinical Trials
3/17/2022
Press Release
eClinical Solutions Drives Strong Annual Growth Marked by New Products, Employee Hirings, and Expansion in West Coast and European Life Science Markets
Business Wire
3/10/2022
Article
Characterizing the Process of Adopting Innovations Supporting Drug Development Operations
Applied Clinical Trials
2/7/2022
Article
Tufts Links Decentralized Clinical Trials to Shorter Cycle Times, Cost Savings
Outsourcing Pharma
1/28/2022
Article
Decentralized Clinical Trials Can Achieve Net Financial Benefits 5 to 14 times
The Health Guild
1/13/2022
Press Release
New Study: Decentralized Clinical Trials Can Achieve Net Financial Benefits of 5X to 14X, Due to Reduced Trial Timelines and Other Factors
Business Wire
1/13/2022
Article
Not Just for a Pandemic: Decentralized Clinical Trials Pay Off Financially, Study Finds
Fierce Biotech
1/12/2022
White Paper
Latest Financial Model Shows Substantial Net Benefits for Sponsors That Use DCTs
Medable
1/12/2022
Article
Trial by fire: More Study Protocols are Experiencing Substantial — and Costly — Changes
STAT News
1/10/2022
Article
To Increase Diversity in Clinical Trials, First Increase Staff Diversity
Tufts Now
12/3/2021
Article
Dedicated Sites, Private Practices Outdoing AMCs on Diversity Front
CenterWatch
11/15/2021
Article
Clinical Trial Sites Face Challenges in Diversifying Personnel and Participants, Study Finds
STAT News
11/5/2021
Article
Race, Ethnicity of Trial Patients 'Highly Correlated' with Staff of Site Investigators: Study
Fierce Biotech
11/3/2021
Article
Diversity of Site Staff Highly Associated with Diversity of Patients Enrolled Trials, According to Tufts
Applied Clinical Trials
11/2/2021
Article
How Medical Affairs Can Contribute to Successful Drug Launch
Pharmaceutical Executive
9/13/2021
Article
We Need Realistic Timelines for Huntington’s Treatments
Huntington's Disease News
8/25/2021
Press Release
Life Sciences BPO Market Top Players Revenue and Forecasts Research
PharmiWeb
8/16/2021
Article
Trump's Antibody Drug Out of Reach for All But 'Rare' Cases
RollCall
10/6/2020
Article
Anti-Infective Drugs Found to Have Lower Total Phase Time Than Other Drugs
Policy & Medicine
9/26/2020
Press Release
New Anti-infective Drugs Had a 14% Speed Advantage vs. Other Drugs During 2000-19, According to Tufts Center for the Study of Drug Development
GlobeNewswire
9/15/2020
Article
Is a Lack of Real-Time Data Holding Trials Back?
PharmaPhorum
9/11/2020
Article
Valuing Innovative Drugs Based On Their Cost Of Manufacturing Will Prolong The Covid-19 Pandemic
Forbes
8/14/2020
Article
Clinical Trials Using Unsophisticated Approaches Despite Availability of Newer Technology
European Pharmaceutical Manufacturer
8/10/2020
Press Release
MEDIA ADVISORY: Expert Commentary and Insight Available on COVID-19 Drug Development
GlobeNewswire
8/6/2020
Article
Diabetes Drug Development Riskier Versus Any Other Therapy Area, Says Tufts CSDD
The Pharma Letter
9/21/2016